Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:358402.
doi: 10.1155/2013/358402. Epub 2013 Nov 3.

Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors

Affiliations

Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors

Nathlee Samantha Abbai et al. J Sex Transm Dis. 2013.

Abstract

Background. Sexually transmitted infections (STIs) continue to be a significant public health problem especially among women of reproductive age in Africa. Methods. A total of 2236 women that had enrolled in the MDP301 vaginal microbicide trial were tested for the presence of Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), Treponema pallidum, and Trichomonas vaginalis (TV). Results. CT was identified as the most prevalent STI (11%) followed by TV (10%), NG, and Syphilis (3%). The highest prevalence of coinfection was reported between T. pallidum and TV (19.67%, P = 0.004), followed by CT and TV (13.52%, P ≤ 0.001). Risk factors that were significantly associated with STI acquisition were women of 23 years of age or younger (HR: 1.50, 95% CI 1.17, 1.93), baseline STI with CT (HR: 1.77, 95% CI 1.32, 2.35), TV (HR: 1.58, 95% CI, 1.20, 2.10), and T. pallidum (HR: 5.13, 95% CI 3.65, 7.22), and a low education level (HR: 1.30, 95% CI 1.02, 1.66). Conclusion. Young women with lower education and a history of STIs are at high risk of multiple STIs. Prevention programs should consider target approach to STI prevention among young women. This trial is registered with ISRCTN64716212.

PubMed Disclaimer

Similar articles

Cited by

References

    1. WHO. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva, Switzerland: WHO; 2012.
    1. White R. G. Curable sexually transmitted infection treatment interventions to prevent hiv transmission in sub-saharan africa. The Open Infectious Diseases Journal. 2009;3:148–155.
    1. Rours G., Verkooyen R., Hop W., et al. Sexually transmitted infections in pregnant urban South-African women: socio-economic characteristics and risk factors. The Southern African Journal of Epidemiology and Infection. 2006;21(1):14–19.
    1. Rours G., Verkooyen R., Hop W., et al. Consequences for pregnancy outcome and infants. The Southern African Journal of Epidemiology and Infection. 2010;21:p. 57.
    1. Wilson J. F. Vaginitis and cervicitis. Annals of Internal Medicine. 2009;151(5, article ITC3-1) - PubMed

LinkOut - more resources